Graham Capital Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-21,803
Closed -$110K – 1241
2025
Q3
$110K Buy
21,803
+8,998
+70% +$39.8K ﹤0.01% 1151
2025
Q2
$51.6K Sell
12,805
-25,652
-67% -$83.5K ﹤0.01% 1243
2025
Q1
$105K Buy
+38,457
New +$138K ﹤0.01% 1207
2023
Q4
– Sell
-10,514
Closed -$27.2K – 1018
2023
Q3
$27.2K Buy
+10,514
New +$36.9K ﹤0.01% 977

Other funds holding SRTA

Graham Capital Management's SRTA Position: Q4 2025 in Review

Graham Capital Management sold out of Strata Critical Medical Inc (SRTA) in Q4 2025, closing a stake of 21,803 shares — an estimated $110K sold.

Graham Capital Management first reported a position in SRTA in Q3 2023 and held it in 4 quarters. The position peaked at $110K in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q4 2025.

  • Graham Capital Management reported no remaining Strata Critical Medical Inc position as of Q4 2025 after selling out during the quarter.
  • Graham Capital Management sold 21,803 Strata Critical Medical Inc shares in Q4 2025, an estimated $110K.
  • Graham Capital Management first reported a position in Strata Critical Medical Inc in Q3 2023 and held it in 4 quarters.
  • Graham Capital Management's Strata Critical Medical Inc position peaked at $110K in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2025.

Based on Graham Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.